Abstract
We report a case of a young Ghanaian male who developed Bleomycin Induced Pneumonitis (BIP) after being treated for Hodgkin's Lymphoma. Pulmonary toxicity is the most feared complication of bleomycin therapy despite its effectiveness in achieving cure in patients with Hodgkin's lymphoma and germ cell tumors. BIP has a significant mortality rate if detected late and a high index of suspicion is required in all patients on bleomycin-based therapies with sudden onset of respiratory symptoms.
Original language | English |
---|---|
Pages (from-to) | 279-283 |
Number of pages | 5 |
Journal | Ghana Medical Journal |
Volume | 54 |
Issue number | 4 |
DOIs | |
Publication status | Published - Dec 2020 |
Keywords
- Bleomycin
- Ghana
- Hodgkin's lymphoma
- Pneumonitis